This is the authors' abstract. We don't add key points for this paper.
The pathogenic bacterium Clostridioides difficile is a major cause of antibiotic-associated diarrheal disease. Treatment of the disease is challenging because antibiotics used for treatment may also perpetuate the conditions that contributed to initial susceptibility. Elucidating the mechanisms of C. difficile /intestinal epithelium interaction is needed to facilitate the development of new therapeutic options. The studies described in this communication demonstrate the development of a tissue culture system that supported the growth of C. difficile in co-culture with a model of the human intestinal epithelium produced from colonoids, organoids derived from human colonic biopsies. Epithelial cell responses to C. difficile included upregulation of CCL20 , encoding a chemokine. Glucosylating toxin production by the bacteria was required for upregulation of CCL20. Additionally, bacteria associated with the monolayer in a non-toxin dependent manner. This system will support future investigation of epithelium/ C. difficile interactions during CDI and identification of mechanisms that drive pathogenesis by C. difficile in the human intestine.
No takes yet. Share an insight, caveat, or question.
Zucchi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: